Michael Skinnider, along with his colleagues, utilized a directory of “known psychoactive substances” from across the globe to equip an artificial intelligence algorithm with drug structure information.
“These molecules were then tested against 196 new designer drugs that emerged on the illicit market after the model was trained.
UBC’s model is being used by the U.S.